Intelligence Β· Patent portfolio
Chinese Academy of Patents
Full USPTO pharma patent portfolio for Chinese Academy of β grant dates, expiration, and drug cross-links.
- Patents
- 335
- Expiring β€24m
- 3
Quick answer
Chinese Academy of has 335 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β use filters for patent-cliff planning.
-
US 8796327
Method for inhibiting production of cytokines of T helper cell type II and/or inhibiting production of chemokines using brazilin
granted -
US 8790695
Medicinal carriers, and preparation method and uses thereof
granted -
US 8729026
Method for inhibiting autophagy of motor neurons
granted -
US 8709784
Use of Lactobacillus for liver protection
granted -
US 8710064
2-aryl-4-quinazolinones and their pharmaceutical compositions
granted -
US 8703208
Nanometer mesoporous silica-based xerogel styptic process and its preparing process and application
granted -
US 8697649
Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
granted -
US 8691796
Pharmaceutical composition and method for inhibiting inflammation
granted -
US 8664238
Indenoisoquinolinone derivatives, manufacturing method and medical use thereof
granted -
US 8609408
Method for the reconstruction of a tissue-engineered human corneal endothelium
granted -
US 8569249
Method for inhibiting activation of macrophages
granted -
US 8501957
Benzimidazole compounds and their use as anticancer agents
granted -
US 8501803
Garcinia derivative, its preparing method and medicinal use
granted -
US 8486898
Compounds and method for inhibiting the activity of gelatinase and collagenase
granted -
US 8480995
Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate
granted -
US 8481095
Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosporylation of mitogen-activated protein kinase using flemingia macrophylla extract
granted -
US 8476229
Blood sugar-modulating polypeptides
granted -
US 8440692
Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents
granted -
US 8415135
Lactobacillus plantarum and uses thereof
granted -
US 8409632
Product containing extract from Zanthoxylum avicennae (Lam.) DC., and preparation process and use thereof
granted -
US 8350065
5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same
granted -
US 8349333
Allergy inhibitor compositions and kits and methods of using the same
granted -
US 8349371
Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosphorylation of mitogen-activated protein kinase using neonauclea reticulata leaf extracts
granted -
US 8283377
Method for inhibiting blood vessel stenosis
granted -
US 8197823
Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof
granted -
US 8084431
Method for inhibiting activation of macrophages, inhibiting formation of osteoclasts, inhibiting function of osteoclasts, and/or activating osteoblasts
granted -
US 7820692
Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
granted -
US 7794730
Polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish
granted -
US 7772230
Chroman compound, processes for its preparation, and its pharmaceutical use
granted -
US 7704976
Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention
granted -
US 7659252
Transdermal delivery peptides and method of use thereof
granted -
US 7655665
Nitromethylene derivatives and their use
granted -
US 7541463
Sulfur-containing naphthalimide derivatives
granted -
US 7345030
Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
granted -
US 7122214
Drynaria extractions for treating osteoporosis and their extraction process
granted -
US 7098364
Phenylethanolamine compounds as Ξ²2-receptor agonists, and methods of use and preparation thereof
granted -
US 7037904
Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy
expired -
US 7015207
Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for preventing and treating sexual disorder
expired -
US 6946452
Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating motion sickness
expired -
US 6897316
Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents
expired -
US 6838490
Silicone rubber in the form of a finely divided powder, method for the production and the use of the same
expired -
US 6747105
Bis-Schiff base ligand-containing mono-metallocene olefin polymerization catalyst, its preparation process and application
expired -
US 6596321
Pharmaceutical composition for treating angiocardiopathy and the method of producing thereof
expired -
US 6573300
Hydroxyurea treatment for spinal muscular atrophy
expired -
US 6333054
Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
expired -
US 6028207
Bone resorption inhibition/osteogenesis promotion compound
expired -
US 6028198
Pharmaceutical composition for prevention and treatment of motion sickness syndrome
expired
Frequently asked questions
How many patents does Chinese Academy of have?
335 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Chinese Academy of patents expire?
3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory